Carrie S. Cox - 13 Jun 2025 Form 4 Insider Report for Organon & Co. (OGN)

Reporting relationship: Director
Issuer ticker: OGN
Reported as of: 13 Jun 2025
Net transaction value: +$240,000
SEC form: 4
Accepted by SEC: 16 Jun 2025, 17:17:16 UTC
Prior SEC filing: 15 May 2025
Next SEC filing: 13 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Carrie Smith Cox

Key filing fact

Carrie S. Cox filed Form 4 for Organon & Co. (OGN) on 16 Jun 2025.

Key facts

This page summarizes Carrie S. Cox's Form 4 filing for Organon & Co. (OGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 17:17.

Change

Previous filing in this sequence was filed on 15 May 2025.
Current net transaction value: +$240,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001110753 Primary reporting owner

COX CARRIE SMITH

Relationship: Director
Address: C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Carrie Smith Cox
Signature date: 16 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Phantom Stock

Award

Transaction value: $240,000
Shares: +23,904
Change %: +48%
Price: $10.04
Shares after: 74,030
Date: 13 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,904
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

Footnote F2

Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

Footnote F3

Holdings include phantom stock units acquired in dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025 and June 12, 2025.